These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 29969172)

  • 21. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control.
    Hu JC; Gandaglia G; Karakiewicz PI; Nguyen PL; Trinh QD; Shih YC; Abdollah F; Chamie K; Wright JL; Ganz PA; Sun M
    Eur Urol; 2014 Oct; 66(4):666-72. PubMed ID: 24602934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy.
    Roberts WW; Bergstralh EJ; Blute ML; Slezak JM; Carducci M; Han M; Epstein JI; Eisenberger MA; Walsh PC; Partin AW
    Urology; 2001 Jun; 57(6):1033-7. PubMed ID: 11377299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy.
    Han M; Snow PB; Epstein JI; Chan TY; Jones KA; Walsh PC; Partin AW
    Urology; 2000 Dec; 56(6):994-9. PubMed ID: 11113746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy.
    Beckmann K; O'Callaghan M; Vincent A; Roder D; Millar J; Evans S; McNeil J; Moretti K
    ANZ J Surg; 2018 Mar; 88(3):E183-E188. PubMed ID: 28471003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Pragmatic Randomized Controlled Trial Examining the Impact of the Retzius-sparing Approach on Early Urinary Continence Recovery After Robot-assisted Radical Prostatectomy.
    Dalela D; Jeong W; Prasad MA; Sood A; Abdollah F; Diaz M; Karabon P; Sammon J; Jamil M; Baize B; Simone A; Menon M
    Eur Urol; 2017 Nov; 72(5):677-685. PubMed ID: 28483330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical margin length and location affect recurrence rates after robotic prostatectomy.
    Dev HS; Wiklund P; Patel V; Parashar D; Palmer K; Nyberg T; Skarecky D; Neal DE; Ahlering T; Sooriakumaran P
    Urol Oncol; 2015 Mar; 33(3):109.e7-13. PubMed ID: 25512161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Dec; 64(6):1165-70. PubMed ID: 15596191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting hospitalization following psychiatric crisis care using machine learning.
    Blankers M; van der Post LFM; Dekker JJM
    BMC Med Inform Decis Mak; 2020 Dec; 20(1):332. PubMed ID: 33302948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial.
    Sooriakumaran P; Pini G; Nyberg T; Derogar M; Carlsson S; Stranne J; Bjartell A; Hugosson J; Steineck G; Wiklund PN
    Eur Urol; 2018 Apr; 73(4):618-627. PubMed ID: 28882327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.
    Herlemann A; Cowan JE; Carroll PR; Cooperberg MR
    Eur Urol; 2018 Feb; 73(2):215-223. PubMed ID: 28499617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-year Outcomes for a Prospective Randomised Controlled Trial Comparing Laparoscopic and Robot-assisted Radical Prostatectomy.
    Porpiglia F; Fiori C; Bertolo R; Manfredi M; Mele F; Checcucci E; De Luca S; Passera R; Scarpa RM
    Eur Urol Focus; 2018 Jan; 4(1):80-86. PubMed ID: 28753822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ; Chopra S; Yu C; Kattan MW; Pinnock C; Kopsaftis T
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.
    Røder MA; Berg KD; Loft MD; Thomsen FB; Ferrari M; Kurbegovic S; Rytgaard HC; Gruschy L; Brasso K; Gerds TA; Kjær A; Brooks JD; Iversen P
    Eur Urol Focus; 2018 Apr; 4(3):360-368. PubMed ID: 28753827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
    Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis.
    Wang L; Wang B; Ai Q; Zhang Y; Lv X; Li H; Ma X; Zhang X
    Int Urol Nephrol; 2017 Jun; 49(6):995-1005. PubMed ID: 28238148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer.
    Lu W; Zhao L; Wang S; Zhang H; Jiang K; Ji J; Chen S; Wang C; Wei C; Zhou R; Wang Z; Li X; Wang F; Wei X; Hou W
    Clin Transl Oncol; 2024 Sep; 26(9):2369-2379. PubMed ID: 38602643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.